Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
El-Damarawi MA, Salama ME
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data
:quality(85):upscale()/2024/09/19/783/n/49351082/2c557c9c66ec63d36577f4.31206634_.jpg)
Lets unpack the science, explore real-world results, and weigh the scalesdo the benefits of GLP-1 drugs outweigh the negatives
The Medicare GLP-1 Bridge is a nationwide CMS demonstration program
Conclusion Health insurers are likely to be or have already been exposed to the rise of GLP-1s, and the exposure is expected to expand with approvals for new indications in the pipeline, as well as a projected increase in take-up rates
It also helps balance blood sugar levels, creating a synergistic effect that supports significant and sustainable weight loss when paired with lifestyle changes such as healthier eating and regular exercise
US$ 25.03
US$ 28.20
:max_bytes(150000):strip_icc()/VWH-GettyImages-1807239973-944cddb21ce647c594217130457b8f00.jpg)
US$ 29.24
US$ 21.26
US$ 26.62
